|
VARIABLES
|
GROUP A (n = 41)
|
GROUP B (n = 35)
|
GROUP C (n = 45)
|
p value
|
|---|
|
Age
|
60,8 +/- 11
|
59,6 +/- 12
|
54 +/- 12
|
0,038
|
|
Gender (male %)
|
51,2
|
54,2
|
65
|
0,47
|
|
Reasons for test:
| | | | |
|
-Investigation for CAD (%)
|
46
|
66
|
55
|
0,23
|
|
-Evaluation of known CAD (%)
|
54
|
34
|
45
|
0,23
|
|
Hypertension (%)
|
61
|
62
|
45
|
0,61
|
|
Diabetes (%)
|
20
|
20
|
21
|
0,98
|
|
Hyperlipemia (%)
|
46
|
62
|
35
|
0,10
|
|
Family history for CAD (%)
|
49
|
60
|
46
|
0,49
|
|
Smoking (%)
|
29
|
31
|
24
|
0,80
|
|
Obesity (%)
|
36
|
28
|
45
|
0,40
|
|
Use of Beta-blocker (%)
|
49
|
54
|
45
|
0,74
|
|
Use of Calcium blocker (%)
|
12
|
20
|
10
|
0,48
|
|
Altered baseline ECG (%)
|
38
|
39
|
41
|
0,97
|
|
Altered baseline Echo (%)
|
41
|
37
|
42
|
0,87
|
|
Normal LV function (%)
|
66
|
86
|
65
|
0,097
|
|
Previous angiography (%)
|
46
|
40
|
36
|
0,68
|
|
Previous PTCA (%)
|
19
|
12
|
10
|
0,60
|
|
Previous CABG (%)
|
17
|
17
|
10
|
0,69
|
- CAD = coronary artery disease, ECG = electrocardiogram,
- Echo = echocardiogram, LV = left ventricle, PTCA = percutaneous transluminal coronary angioplasty,
- CABG = coronary artery bypass graft.
